Article
I'm sure that if a hundred dermatologists were asked to compile a list of the 10 most important innovations in dermatologic drugs and devices that have occurred over the past 15 years, the lists would be remarkably similar.
The Weekly Roundup: October 7-11
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Safe and Effective: Upadacitinib Shows Promise in PN Treatment
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Fourth Ustekinumab Biosimilar, Otulfi, Approved in US
Philip Mease, MD, Discusses Head-to-Head BE BOLD Clinical Trial